Truist Financial’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113M Buy
666,343
+24,320
+4% +$4.16M 0.15% 136
2025
Q4
$108M Buy
642,023
+614,582
+2,240% +$99.8M 0.14% 137
2025
Q3
$3.96M Sell
27,441
-920
-3% -$126K 0.01% 1002
2025
Q2
$3.59M Sell
28,361
-17,325
-38% -$2.13M 0.01% 1007
2025
Q1
$5.84M Sell
45,686
-7,201
-14% -$976K 0.01% 763
2024
Q4
$6.99M Buy
52,887
+14,770
+39% +$2.08M 0.01% 691
2024
Q3
$5.55M Buy
38,117
+2,758
+8% +$399K 0.01% 790
2024
Q2
$4.85M Sell
35,359
-36,325
-51% -$4.85M 0.01% 873
2024
Q1
$9.84M Buy
71,684
+44,682
+165% +$6.1M 0.01% 632
2023
Q4
$3.67M Sell
27,002
-11,120
-29% -$1.36M 0.01% 982
2023
Q3
$4.66M Sell
38,122
-27,146
-42% -$3.45M 0.01% 865
2023
Q2
$8.29M Sell
65,268
-14,648
-18% -$1.9M 0.01% 650
2023
Q1
$10.3M Buy
79,916
+5,709
+8% +$747K 0.02% 581
2022
Q4
$9.74M Buy
74,207
+1,035
+1% +$134K 0.02% 579
2022
Q3
$8.56M Buy
73,172
+12,890
+21% +$1.6M 0.02% 604
2022
Q2
$7.09M Sell
60,282
-16,113
-21% -$1.91M 0.01% 691
2022
Q1
$9.95M Sell
76,395
-24,503
-24% -$3.19M 0.02% 636
2021
Q4
$15.4M Buy
100,898
+4,128
+4% +$639K 0.02% 509
2021
Q3
$15.6M Buy
96,770
+2,494
+3% +$420K 0.03% 486
2021
Q2
$15.4M Buy
94,276
+5,308
+6% +$818K 0.03% 501
2021
Q1
$13.4M Buy
88,968
+197
+0.2% +$31.3K 0.02% 524
2020
Q4
$13.4M Buy
88,771
+8,766
+11% +$1.25M 0.03% 517
2020
Q3
$10.8M Buy
80,005
+8,004
+11% +$1.09M 0.02% 527
2020
Q2
$9.84M Buy
72,001
+26,338
+58% +$3.36M 0.02% 533
2020
Q1
$4.92M Sell
45,663
-23,994
-34% -$2.76M 0.01% 684
2019
Q4
$8.39M Buy
+69,657
New +$7.77M 0.02% 621
2018
Q4
Sell
-2,571
Closed -$314K 771
2018
Q3
$314K Buy
2,571
+508
+25% +$59.8K 0.01% 673
2018
Q2
$226K Buy
+2,063
New +$221K ﹤0.01% 716

Other funds holding IBB